BacLite Rapid MRSA Clinical Performance
NCT00541632 · Status: TERMINATED · Type: OBSERVATIONAL
Last updated 2024-12-02
Summary
The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.
Conditions
- Methicillin Resistance
Sponsors & Collaborators
-
3M
collaborator INDUSTRY -
Solventum US LLC
lead INDUSTRY
Principal Investigators
-
Werner E Bischoff · Wake Forest University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2008-03-31
- Completion
- 2008-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
NCT00711854 ·Status: COMPLETED ·Phase: PHASE4
-
MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial
NCT00814151 ·Status: COMPLETED
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208 ·Status: COMPLETED ·Phase: NA
-
Retapamulin for Reducing MRSA Nasal Carriage
NCT01461668 ·Status: COMPLETED ·Phase: PHASE4
-
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00087490 ·Status: COMPLETED ·Phase: PHASE4
-
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
NCT00852540 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00846105 ·Status: COMPLETED ·Phase: NA
-
A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
NCT05225558 ·Status: TERMINATED ·Phase: PHASE2
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NCT02862262 ·Status: COMPLETED ·Phase: NA
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495 ·Status: WITHDRAWN ·Phase: NA
-
Preview Rapid Strep A Test Method Comparison Study
NCT03907449 ·Status: SUSPENDED
-
Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside
NCT00247871 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus
NCT04767321 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus
NCT05889351 ·Status: COMPLETED ·Phase: PHASE2
-
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545 ·Status: RECRUITING ·Phase: PHASE4
-
ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
NCT05329168 ·Status: WITHDRAWN ·Phase: PHASE2
-
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
NCT03361163 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Mupirocin Decolonization on the Nasal Microbiome
NCT02045329 ·Status: TERMINATED
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
MRSA Decolonization in Complicated Carriage
NCT05268120 ·Status: RECRUITING ·Phase: NA
-
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine
NCT01311817 ·Status: COMPLETED ·Phase: PHASE1